Subject: Immune Response Stock Jumps as Study Of Vaccine Evaluated
Date: Published: 4/13/93 (41 lines)
Source: Wall Street Journal. Copyright Dow Jones & Co. Inc.

    Technology:
    Immune Response
    Stock Jumps as Study
    Of Vaccine Evaluated

    SAN DIEGO -- Immune Response Corp. said clinical trial results of
 its vaccine against human immunodeficiency virus infection are being
 evaluated by the company and its partner, but wouldn't indicate the
 results.
    In national over-the-counter trading Monday, Immune Response
 shares rose 23%, or $2.50, to $13.25, on 2.3 million shares.
    Jim Glavin, president and chief executive, said he tried to
 discourage assumptions on Wall Street that no news is good news.  The
 clinical trials were completed in September.
    "I think there was some speculation that if we had any
 opportunity to analyze data at all and it was negative, that
 something would be out by now," he said.  "I tried to dispel that."
    The company and its partner, Rhone-Poulenc Rorer Inc., recently
 "unblinded" the clinical trial results, allowing researchers to
 compare treated control groups.  But Immune Response said it wouldn't
 publicly discuss the results of its AIDS-virus vaccine until
 analysis is complete.  Immune Response will present data at an AIDS
 conference in Berlin in June.
    Immune Response and Rhone-Poulenc Rorer, a unit of the French
 pharmaceutical company Rhone-Poulenc SA, also said their joint
 venture acquired additional rights to the vaccine in Europe, Africa,
 and Central and South America.  The joint venture already has U. S. 
 rights to the product.
    Mr. Glavin said "no funds changed hands" for the additional
 rights from Pasteur Merieux Connaught Group, a unit of Institut
 Merieux, which retains distribution rights for the vaccine in Canada
 and France.

[This article is made available here by Dow Jones Co. for the
 personal and non-commercial use of callers to this bbs, in the
 hope that it will be of some help to those who are suffering
 from the disease and others who are seeking to help them.]